Nora Isberner
Impact in
-
- Chronic Myeloid Leukemia Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- COVID-19 Clinical Research Studies 4
- Genetics 5
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Hartwig Klinker (9 shared papers)Oliver Scherf‐Clavel (7 shared papers)Max Kurlbaum (6 shared papers)Theo Pelzer (3 shared papers)Sabrina Kraus (6 shared papers)Götz Ulrich Grigoleit (6 shared papers)Maria-Elisabeth Goebeler (3 shared papers)Charis Kalogirou (3 shared papers)
In The Last Decade
Nora Isberner
13 papers receiving 139 citations
Peers
Comparison fields: 5 of 49
- Hematology 27
- Genetics 25
- Infectious Diseases 34
- Immunology 36
- Transplantation 4
Countries citing papers authored by Nora Isberner
This map shows the geographic impact of Nora Isberner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Isberner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Isberner more than expected).
Fields of papers citing papers by Nora Isberner
This network shows the impact of papers produced by Nora Isberner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Isberner. The network helps show where Nora Isberner may publish in the future.
Co-authors
The 25 scholars most cited alongside Nora Isberner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 34 | |
| 2 | 2022 | 23 | |
| 3 | 2021 | 12 | |
| 4 | 2021 | 12 | |
| 5 | 2021 | 10 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 8 | |
| 9 | 2020 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 4 | |
| 14 | COVID-19 in cancer patients: Clinical characteristics and outcome - a first analysis of the LEOSS registry | 2020 | 0 |
About Nora Isberner
Nora Isberner is a scholar working on Infectious Diseases, Genetics, Oncology, Hematology and Molecular Biology, having authored 14 papers that have together received 140 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), COVID-19 Clinical Research Studies (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), CAR-T cell therapy research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Cytomegalovirus and herpesvirus research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Hematology (27 citations), Genetics (25 citations), Infectious Diseases (34 citations), Immunology (36 citations) and Transplantation (4 citations). Nora Isberner has collaborated with scholars based in Germany, France and China. Frequent co-authors include Hartwig Klinker, Oliver Scherf‐Clavel, Max Kurlbaum, Theo Pelzer, Sabrina Kraus, Götz Ulrich Grigoleit, Maria-Elisabeth Goebeler, Charis Kalogirou, Bastian Schilling and Siegbert Rieg. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Analytical and Bioanalytical Chemistry, Cancers, Infection and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.